|
SPIN3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.316970E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.810000E-01 |
| Normal-vs-Stage2 |
6.882600E-01 |
| Normal-vs-Stage3 |
5.094400E-02 |
| Normal-vs-Stage4 |
1.196990E-01 |
| Stage1-vs-Stage2 |
7.937200E-01 |
| Stage1-vs-Stage3 |
1.425420E-01 |
| Stage1-vs-Stage4 |
3.398200E-01 |
| Stage2-vs-Stage3 |
2.603200E-01 |
| Stage2-vs-Stage4 |
3.858800E-01 |
| Stage3-vs-Stage4 |
7.537000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.060300E-02 |
| Normal-vs-AfricanAmerican |
7.590600E-01 |
| Normal-vs-Asian |
1.571980E-01 |
| Caucasian-vs-AfricanAmerican |
3.242400E-01 |
| Caucasian-vs-Asian |
7.500200E-02 |
| AfricanAmerican-vs-Asian |
1.943980E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.812000E-02 |
| Normal-vs-Female |
3.578200E-01 |
| Male-vs-Female |
4.079800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.395900E-02 |
| Normal-vs-Age(41-60Yrs) |
4.512600E-01 |
| Normal-vs-Age(61-80Yrs) |
9.648200E-02 |
| Normal-vs-Age(81-100Yrs) |
3.338200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.421200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.737800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.068800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.053800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.278400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.878000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.072800E-01 |
| Normal-vs-Grade 2 |
6.964000E-01 |
| Normal-vs-Grade 3 |
1.118180E-01 |
| Normal-vs-Grade 4 |
7.186200E-04 |
| Grade 1-vs-Grade 2 |
1.973560E-01 |
| Grade 1-vs-Grade 3 |
5.552500E-02 |
| Grade 1-vs-Grade 4 |
3.257600E-03 |
| Grade 2-vs-Grade 3 |
9.580000E-02 |
| Grade 2-vs-Grade 4 |
9.186600E-04 |
| Grade 3-vs-Grade 4 |
3.157700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
9.462400E-01 |
| Normal-vs-ccB subtype |
2.735900E-02 |
| ccA subtype-vs-ccB subtype |
9.660100E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.619800E-01 |
| Normal-vs-N1 |
2.344200E-02 |
| N0-vs-N1 |
1.538180E-01 |
|
|
